Shyam Nyati

8PUBLICATIONS
3CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 26, 2026
BUB1 and CDK4/6 Dual Inhibition Increases Radiation Sensitivity in Glioblastoma, Lung Cancer, and Triple-Negative Breast Cancer.

|Oct 16, 2024
BUB1 Inhibition Overcomes Radio- and Chemoradiation Resistance in Lung Cancer.

Shivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan

|Oct 16, 2024
Present and Future of Immunotherapy for Triple-Negative Breast Cancer.

Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers

|Sep 28, 2024
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses.

Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu

|Jun 27, 2024
BUB1 Inhibition Sensitizes TNBC Cell Lines to Chemotherapy and Radiotherapy.

Sushmitha Sriramulu, Shivani Thoidingjam, Farzan Siddiqui

|May 25, 2024
Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer.

Aseem Rai Bhatnagar, Farzan Siddiqui, Gazala Khan

Pageof 2

Frequent Collaborators

2 joint publications

Aseem Rai Bhatnagar

1 joint publications

Shirish Gadgeel

1 joint publications

Asya Haider Muratoglu